4/A//SEC Filing
Deming David H 4/A
Accession 0001144204-17-048376
CIK 0000850261other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 6:18 AM ET
Size
5.9 KB
Accession
0001144204-17-048376
Insider Transaction Report
Form 4/AAmended
Deming David H
Director
Transactions
- Award
Stock Options
2017-09-15+35,000→ 35,000 totalExercise: $1.80Exp: 2027-09-15→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]This amended report on Form 4 is being filed to amend the Form 4 filed by the reporting person on September 15, 2017 to correct the exercise price, which was inadvertently reported as $1.75.
- [F2]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001641063
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 6:18 AM ET
- Size
- 5.9 KB